ClinicalTrials.Veeva

Menu
P

Precision Cancer Centers | Ashland-Bellefonte Cancer Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Estrogen
Platinum
Neratinib
Injectafer
Palonosetron
Docetaxel
Pegfilgrastim
Luspatercept
Debio 1143

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

This Phase II, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant compared with physician's choice of en...

Active, not recruiting
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Drug: Fulvestrant or an Aromatase Inhibitor (Physician Choice)
Drug: LHRH Agonist

This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) befor...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Placebo
Drug: Pemetrexed

Trial sponsors

Puma Biotechnology logo
Roche logo
American Regent logo
Celgene logo
G
Gilead Sciences logo
H
H
Merck KGaA (EMD Serono) logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems